GLP-1 agonists reduce risk of suicidal thoughts in adolescents
A cohort study by Israeli scientists found that adolescents treated with glucagon-like peptide-1 (GLP-1) receptor agonists had a 33 percent lower risk of having suicidal thoughts or attempts compared with controls…